Your browser doesn't support javascript.
loading
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.
Levine, John E; Grupp, Stephan A; Pulsipher, Michael A; Dietz, Andrew C; Rives, Susana; Myers, G Douglas; August, Keith J; Verneris, Michael R; Buechner, Jochen; Laetsch, Theodore W; Bittencourt, Henrique; Baruchel, Andre; Boyer, Michael W; De Moerloose, Barbara; Qayed, Muna; Davies, Stella M; Phillips, Christine L; Driscoll, Timothy A; Bader, Peter; Schlis, Krysta; Wood, Patricia A; Mody, Rajen; Yi, Lan; Leung, Mimi; Eldjerou, Lamis K; June, Carl H; Maude, Shannon L.
Afiliação
  • Levine JE; Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, Michigan, USA.
  • Grupp SA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Pulsipher MA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Dietz AC; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Rives S; Section of Transplantation and Cellular Therapy, Children's Hospital Los Angeles Cancer and Blood Disease Institute, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Myers GD; Section of Transplantation and Cellular Therapy, Children's Hospital Los Angeles Cancer and Blood Disease Institute, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • August KJ; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain.
  • Verneris MR; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Buechner J; Children's Mercy Hospital Kansas City, Kansas City, Missouri, USA.
  • Laetsch TW; Children's Mercy Hospital Kansas City, Kansas City, Missouri, USA.
  • Bittencourt H; Division of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis, Minnesota, USA.
  • Baruchel A; Department of BMT and Cellular Therapy, Children's Hospital Colorado, University of Colorado, Boulder, Colorado, USA.
  • Boyer MW; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
  • De Moerloose B; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Qayed M; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Davies SM; Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Phillips CL; Pauline Allen Gill Center for Cancer and Blood Disorders, Children's Health, Dallas, Texas, USA.
  • Driscoll TA; Hematology Oncology Division, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montreal, Québec, Canada.
  • Bader P; Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, Québec, Canada.
  • Schlis K; Pediatric Hematology-Immunology Department, University Hospital Robert Debré (APHP) and Université de Paris, Paris, France.
  • Wood PA; Department of Pediatrics and Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Mody R; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
  • Yi L; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Leung M; Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, Georgia, USA.
  • Eldjerou LK; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
  • June CH; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Maude SL; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
J Immunother Cancer ; 9(8)2021 08.
Article em En | MEDLINE | ID: mdl-34353848
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos